المؤلفون: Lissette Batista, Joan Falco, Eva Criado, Jordi Ortiz, Beatriz Arau, Mercè Rosinach, Caridad Garcia, Jordi Sánchez-Delgado, Montserrat Forné, Meritxell Casas, Mireia Miquel, Blai Dalmau, Mercè Roget, Pau Sort, Salvador Machlab, Carlos Gómez Zaragoza, Alba Lira, Mercedes Vergara

المصدر: European Journal of Gastroenterology & Hepatology. 30:1453-1460

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Carcinoma, Hepatocellular, Kaplan-Meier Estimate, Risk Assessment, Intermediate stage, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Overall survival, Carcinoma, Humans, Chemoembolization, Therapeutic, Aged, Antibiotics, Antineoplastic, Hepatology, Drug eluting beads, business.industry, Liver Neoplasms, Gastroenterology, Follow up studies, Prognosis, medicine.disease, Microspheres, digestive system diseases, Treatment Outcome, Multicenter study, Doxorubicin, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Female, 030211 gastroenterology & hepatology, business, Liver cancer, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea55d01db8c11414bcdeff3d074e6655
https://doi.org/10.1097/meg.0000000000001229